Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.1920
-0.0380 (-16.52%)
Last updated: Nov 10, 2025, 5:04 PM CET
EPA:ALVIO Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1.83 | 1.79 | 1.8 | 1.44 | 4.06 | 1.78 | Upgrade |
| 1.83 | 1.79 | 1.8 | 1.44 | 4.06 | 1.78 | Upgrade | |
Revenue Growth (YoY) | -3.12% | -0.39% | 24.74% | -64.48% | 128.72% | -58.59% | Upgrade |
Cost of Revenue | 0.74 | 0.51 | 0.53 | 0.51 | 0.37 | 0.35 | Upgrade |
Gross Profit | 1.09 | 1.28 | 1.27 | 0.93 | 3.69 | 1.43 | Upgrade |
Selling, General & Admin | 6.96 | 13.95 | 19.57 | 18.02 | 8.12 | 8.15 | Upgrade |
Other Operating Expenses | -2.23 | 0.56 | 0.27 | 0.03 | 0.69 | 0.48 | Upgrade |
Operating Expenses | 6.57 | 17.77 | 20.32 | 18.04 | 9.28 | 9.24 | Upgrade |
Operating Income | -5.49 | -16.49 | -19.05 | -17.11 | -5.58 | -7.81 | Upgrade |
Interest Expense | -0.41 | -0.31 | -0.21 | -2.19 | -0.85 | -0.96 | Upgrade |
Interest & Investment Income | 0.48 | 0.48 | 0.17 | 0.14 | 0.01 | 0 | Upgrade |
Earnings From Equity Investments | -8.02 | -8.02 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | -0.15 | 0 | -0 | -0.5 | 0.15 | 0.61 | Upgrade |
EBT Excluding Unusual Items | -13.59 | -24.34 | -19.09 | -19.67 | -6.28 | -8.16 | Upgrade |
Other Unusual Items | 0.79 | 0.79 | -1.23 | 0.39 | 0.44 | 10.01 | Upgrade |
Pretax Income | -12.8 | -23.55 | -20.33 | -19.28 | -5.84 | 1.85 | Upgrade |
Income Tax Expense | 0.38 | 0.38 | 0.02 | 0.29 | 0.1 | 0.76 | Upgrade |
Net Income | -13.18 | -23.93 | -20.34 | -19.56 | -5.94 | 1.09 | Upgrade |
Net Income to Common | -13.18 | -23.93 | -20.34 | -19.56 | -5.94 | 1.09 | Upgrade |
Shares Outstanding (Basic) | - | 154 | 135 | 106 | 88 | 73 | Upgrade |
Shares Outstanding (Diluted) | - | 154 | 135 | 106 | 88 | 75 | Upgrade |
Shares Change (YoY) | - | 13.81% | 27.86% | 19.88% | 17.03% | 23.61% | Upgrade |
EPS (Basic) | - | -0.16 | -0.15 | -0.18 | -0.07 | 0.01 | Upgrade |
EPS (Diluted) | - | -0.16 | -0.15 | -0.18 | -0.07 | 0.01 | Upgrade |
Free Cash Flow | -9.62 | -12.78 | -17.57 | -9.93 | -8.71 | -4.8 | Upgrade |
Free Cash Flow Per Share | - | -0.08 | -0.13 | -0.09 | -0.10 | -0.06 | Upgrade |
Gross Margin | 59.34% | 71.39% | 70.39% | 64.38% | 90.94% | 80.46% | Upgrade |
Operating Margin | -299.89% | -919.69% | -1058.50% | -1185.93% | -137.42% | -439.98% | Upgrade |
Profit Margin | -720.27% | -1334.69% | -1130.22% | -1355.65% | -146.16% | 61.32% | Upgrade |
Free Cash Flow Margin | -525.41% | -712.72% | -976.33% | -688.22% | -214.45% | -270.10% | Upgrade |
EBITDA | 5.71 | -3.9 | -18.92 | -17.04 | -5.54 | -7.69 | Upgrade |
EBITDA Margin | 311.91% | -217.29% | - | - | -136.26% | - | Upgrade |
D&A For EBITDA | 11.2 | 12.59 | 0.14 | 0.08 | 0.05 | 0.12 | Upgrade |
EBIT | -5.49 | -16.49 | -19.05 | -17.11 | -5.58 | -7.81 | Upgrade |
EBIT Margin | -299.89% | - | - | - | -137.42% | - | Upgrade |
Effective Tax Rate | - | - | - | - | - | 41.01% | Upgrade |
Revenue as Reported | - | - | - | - | - | 1.78 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.